Core Labs > Proteomics Core Proteomics Core
Core Director: Silvia Corvera, M.D. (U. Mass. Medical School)
Specific AimsIn addition to changes in the levels of specific gene transcripts, cellular processes are regulated by mechanisms that occur subsequent to transcription. Post-transcriptional control mechanisms can determine both the levels and functional properties of specific gene products by controlling protein half-lives, activity and/or subcellular localizations. Thus, a direct analysis of proteins is necessary to obtain a complete and accurate picture of the molecular architecture of cells and tissues relevant to type 2 diabetes and of their alterations in disease.
Background and Preliminary DataMass Spectrometry Fingerprinting and Database Correlation Analysis. As the sequencing of the genomes of many model organisms comes to completion the likelihood that a protein from the organism's proteome can be found in the protein database has increased exponentially. This has precipitated a revolution in the application of mass spectrometric techniques in the identification of proteins in the databases (1-3). Highly accurate measurements of peptide masses, as well as isolation and fragmentational analysis of individual peptides can be achieved with both MALDI and ESI mass spectrometers. Database searches can be based on the collective analysis of a number of peptides (MS) or on a single peptide and fragments derived from it by a collisional or decay process (MS/MS). The success of these identification methods is based on a correlation analysis with pre-existing sequences found in the databases and not on any de-novo interpretation of MS/MS spectral data. The UMass Proteomics Core laboratory is equipped with state-of the-art MALDI-TOF instrumentation (Axima CFR from Kratos Analytical). This instrument is used to identify proteins by both MS data from peptide digests as well as MS/MS data derived from post-source-decay (PSD) analysis of individual peptides using the Protein Prospector program developed by Peter Baker and Karl Clauser at UCSF. The Core also has an ESI quadrapole ion trap mass spectrometer (LCQ Deca) from Finnigan, and a capillary HPLC system for direct coupling to perform LC/MS. This instrument is used to automatically acquire high quality MS/MS spectra in a data dependent fashion, followed by database searching using the SEQUEST software developed by John Yates and Jimmy Eng at the University of Washington. By directly coupling to an HPLC for initial peptide fractionation one can analyze complex protein mixtures since only MS/MS data is used to search the database. This instrument system is particularly useful for the deconvolution of protein mixtures. Methodology for Separation of Proteins before Mass SpectrometryThe use of mass spectrometry fingerprinting of proteins requires their previous separation into unique proteins or simple protein mixtures. The single, classical approach consists in the separation of protein mixtures on 2D gels. The first dimension relies on differences in isoelectric point of proteins, while the second dimension is typically SDS-PAGE, which separates proteins by relative mass. Well known disadvantages of this procedure include relatively low sensitivity due to the capacity limitation of isoelectric focussing gels, the need for sophisticated imaging software to accurately compare two or more gels, and the impossibility of separating hydrophobic proteins (4). We have tested whether comprehensive proteome analysis can be achieved through the separation of complex protein mixtures in the first dimension on the basis of alternative physical/biological properties. The sedimentation coefficient of a protein varies with its size and shape, as well as with biological parameters that pertain to individual proteins, such as their monomeric or oligomeric state. We have found that both cytosolic and membrane-associated proteins distribute into well separated bands along both the horizontal and vertical axes of SDS-polyacrylamide gels after velocity gradient centrifugation (VGC) (Figures A1 and A2, UMass Proteomics Core Appendix). Comparison of corresponding fractions derived from independent gradients on adjacent lanes on the SDS-PAGE gel reveals the reproducibility of each gradient to be high. Furthermore, the amount of protein that can be analyzed (milligrams) is orders of magnitude higher than that amenable to separation by isolectric focusing, allowing for the exact identification of each band by mass spectrometry. Two crucial parameters in assessing quantitative changes in protein levels are the sensitivity and linearity of the detection method. We find these parameters to be optimized with a new fluorescent protein stain, SyproRubyTM (Figure A3, UMass Proteomics Core Appendix). The combined use of VGC/SDS-PAGE and SyproRuby staining has proved adequate for the identification of changes in protein composition in cells subjected to diverse perturbations. For example, extracts from 3T3-L1 cells treated for 24 hr with Rosiglitazone (BRL49653), a known insulin sensitizer (5), display multiple changes in the levels of cytosolic bands, many of which correspond to enzymes involved in lipid metabolism.. In addition, significant increases are seen in proteins from the particulate fraction, many of which were identified as mitochondrial components. Research Design and Methods
Aim 1. The Proteomics Core will work with the DGAP Bioinformatics Core to complement annotation of Genomics databases generated by DGAP investigators. A systematic method of reference to specific regions within the VGC/SDS-PAGE proteomic fingerprints will be developed, as well as nomenclature to describe parameters relevant to each protein such as copies per cell and/or copies per organelle, apparent mass and sedimentation coefficient, and tyrosine phosphorylation state. A mutually accessible database of proteins identified by MS/MS or LC/MS will be generated, with suitable links to genomic databases. Related Projects
|
Copyright © 2002 by Diabetes Genome Anatomy Project. All rights reserved. All documents on this Web site are the property of Diabetes Genome Anatomy Project and are protected by copyright. Any reproduction of any document on this Web site which omits Joslin's name or copyright notice is prohibited. Documents on this Web site may be reproduced for personal use only. They may not be distributed or sold. They may not be published in any other format (e.g., book, article, Web site) without the prior, written permission of Diabetes Genome Anatomy Project.
Please contact the webmaster with questions, comments, or suggestions.